Archive - WJSAM Finance Hub

Former progressive makes STUNNING admission on BLM

Former progressive makes STUNNING admission on BLM

What Makes BioMarin (BMRN) so Attractive

What Makes BioMarin (BMRN) so Attractive

Summit Therapeutics (SMMT) Grabs Investor Attention After Major FDA Breakthrough

Summit Therapeutics (SMMT) Grabs Investor Attention After Major FDA Breakthrough

FDA Guidance on MRD Negativity Bodes Well for Legend Biotech (LEGN)

FDA Guidance on MRD Negativity Bodes Well for Legend Biotech (LEGN)

Soleno Therapeutics (SLNO) Sparks Confidence Amid Topline Outperformance

Soleno Therapeutics (SLNO) Sparks Confidence Amid Topline Outperformance

FDA-Issued CRL for Relacorilant NDA Leads to Bullish Views Around Corcept Therapeutics (CORT)

FDA-Issued CRL for Relacorilant NDA Leads to Bullish Views Around Corcept Therapeutics (CORT)

Strong Rare Disease Pipeline Drives Favorable Sentiment for Ultragenyx (RARE)

Strong Rare Disease Pipeline Drives Favorable Sentiment for Ultragenyx (RARE)

Wave Life Sciences (WVE) to Benefit From Optimism Surrounding Alpha-1 Antitrypsin Deficiency Program

Wave Life Sciences (WVE) to Benefit From Optimism Surrounding Alpha-1 Antitrypsin Deficiency Program

Dyne Therapeutics (DYN) Attains Orphan Drug Designation From Japanese Ministry

Dyne Therapeutics (DYN) Attains Orphan Drug Designation From Japanese Ministry

Impressive Clinical Pipeline Leads to Bullish Sentiment for Vaxcyte (PCVX)

Impressive Clinical Pipeline Leads to Bullish Sentiment for Vaxcyte (PCVX)

Latest

Former progressive makes STUNNING admission on BLM

Former progressive makes STUNNING admission on BLM...

4 months ago 50

What Makes BioMarin (BMRN) so Attractive

What Makes BioMarin (BMRN) so Attractive

4 months ago 35

Summit Therapeutics (SMMT) Grabs Investor Attention After Major FDA Breakthrough

Summit Therapeutics (SMMT) Grabs Investor Attentio...

4 months ago 33

FDA Guidance on MRD Negativity Bodes Well for Legend Biotech (LEGN)

FDA Guidance on MRD Negativity Bodes Well for Lege...

4 months ago 36

Soleno Therapeutics (SLNO) Sparks Confidence Amid Topline Outperformance

Soleno Therapeutics (SLNO) Sparks Confidence Amid ...

4 months ago 36

FDA-Issued CRL for Relacorilant NDA Leads to Bullish Views Around Corcept Therapeutics (CORT)

FDA-Issued CRL for Relacorilant NDA Leads to Bulli...

4 months ago 30

Strong Rare Disease Pipeline Drives Favorable Sentiment for Ultragenyx (RARE)

Strong Rare Disease Pipeline Drives Favorable Sent...

4 months ago 35

Wave Life Sciences (WVE) to Benefit From Optimism Surrounding Alpha-1 Antitrypsin Deficiency Program

Wave Life Sciences (WVE) to Benefit From Optimism ...

4 months ago 35

Dyne Therapeutics (DYN) Attains Orphan Drug Designation From Japanese Ministry

Dyne Therapeutics (DYN) Attains Orphan Drug Design...

4 months ago 29

Impressive Clinical Pipeline Leads to Bullish Sentiment for Vaxcyte (PCVX)

Impressive Clinical Pipeline Leads to Bullish Sent...

4 months ago 31

Stifel Initiates Coverage on Olema Pharmaceuticals (OLMA) With Buy Rating

Stifel Initiates Coverage on Olema Pharmaceuticals...

4 months ago 24

Here is Why Beam Therapeutics (BEAM) Appears so Attractive

Here is Why Beam Therapeutics (BEAM) Appears so At...

4 months ago 32

Guggenheim Raises Price Target for Praxis Precision Medicines (PRAX)

Guggenheim Raises Price Target for Praxis Precisio...

4 months ago 29

Orexin-2 Receptor Data Reinforces a Positive Outlook for Centessa (CNTA)

Orexin-2 Receptor Data Reinforces a Positive Outlo...

4 months ago 32

Spyre Therapeutics (SYRE) Set POC Readout Priorities for 2026

Spyre Therapeutics (SYRE) Set POC Readout Prioriti...

4 months ago 33

Atacicept’s Potential Approval Drives Favorable Views on Vera Therapeutics (VERA)

Atacicept’s Potential Approval Drives Favorable Vi...

4 months ago 26

Arcellx (ACLX) Shares Encouraging Data on Latest Laboratory Study

Arcellx (ACLX) Shares Encouraging Data on Latest L...

4 months ago 30

Here is Why Apogee Therapeutics (APGE) Appears Attractive

Here is Why Apogee Therapeutics (APGE) Appears Att...

4 months ago 27